Format

Send to

Choose Destination
Lancet Oncol. 2019 Nov;20(11):e609-e610. doi: 10.1016/S1470-2045(19)30654-0.

What is the best PET target for early biochemical recurrence of prostate cancer?-Authors' reply.

Author information

1
Ahmanson Translational Theranostics Division, Department of Medical and Molecular Pharmacology, University of California Los Angeles, CA 900095-7370, USA; Institute of Urologic Oncology, University of California Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, CA, USA. Electronic address: jcalais@mednet.ucla.edu.
2
Ahmanson Translational Theranostics Division, Department of Medical and Molecular Pharmacology, University of California Los Angeles, CA 900095-7370, USA; Nuclear Medicine, Department of Medical Sciences, University of Turin, Italy.
3
Ahmanson Translational Theranostics Division, Department of Medical and Molecular Pharmacology, University of California Los Angeles, CA 900095-7370, USA; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
4
Department of Radiology and Biomedical Imaging, University of California San Francisco, CA, USA.
5
Molecular Imaging and Nuclear Medicine Therapeutics, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.
6
Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
7
Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
8
Ahmanson Translational Theranostics Division, Department of Medical and Molecular Pharmacology, University of California Los Angeles, CA 900095-7370, USA; Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
9
Ahmanson Translational Theranostics Division, Department of Medical and Molecular Pharmacology, University of California Los Angeles, CA 900095-7370, USA; Institute of Urologic Oncology, University of California Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, CA, USA.

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center